NORTRIPTYLINE HYDROCHLORIDE
Post-LOEANDAORALCAPSULE
Approved
Apr 1996
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
NORTRIPTYLINE HYDROCHLORIDE by Teva is clinical pharmacology the mechanism of mood elevation by tricyclic antidepressants is at present unknown. First approved in 1996.
Drug data last refreshed 20h ago
Mechanism of Action
CLINICAL PHARMACOLOGY The mechanism of mood elevation by tricyclic antidepressants is at present unknown. Nortriptyline hydrochloride is not a monoamine oxidase inhibitor. It inhibits the activity of such diverse agents as histamine, 5-hydroxytryptamine, and acetylcholine. It increases the pressor…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
Worked on NORTRIPTYLINE HYDROCHLORIDE at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.